Report Description

United Kingdom generic drugs market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027. The market growth can be attributed to growing instances of chronic diseases. Rising demands for the prolonged dosages for the treatment for various diseases instances of which is further rising and driving the growth of the United Kingdom generic drugs market in the upcoming five years. Additionally, increasing application of the robotic process automation and expiring branded medicine patents also fuel the growth of the United Kingdom generic drugs market in the future years.

Generic drugs are medicines that has exactly same active ingredients, same safety standards, are equally effective, and are of high quality as much as the branded drugs but are much cheaper than the branded drugs. Dosage, therapeutic activity, administration, and formulation of the generic drug is exactly same as that of the branded drugs. The major difference between the two is the cost of drugs and inert ingredients that give the drug its color, shape or taste. Manufacturing of generic drug may only take place once the patent of the branded drug expires. In that case, the chemical formula of the drug is duplicated, with minor changes to the salt that may or may not occur, is manufactured. The generic drugs do not require extensive clinical trials to prove safety and its efficiency. If the molecule formula and safety standards are followed during the manufacturing the drug is soon released in the market thus making the manufacturing process cost-efficient thus the low prices of the drugs.  

Expanding Pharmaceutical Industry Promises Market Growth

Pharmaceutical industry is rapidly expanding in the country through higher demands for the potent products and increasing dependency of the population over drugs and medicines. Higher investments in the pharmaceutical industry and competitors in the industry actively investing their resources toward increasing manufacture of the generic drugs facilitates the growth of the United Kingdom generic drugs market in the upcoming five years.

In 2019, the annual turnover of pharmaceutical goods wholesalers in the UK was over USD63 billion. Imports of pharmaceutical products from other countries have considerably decreased in 2020 valued at USD20,871 million from USD23,458 million in the year 2019. Decreased imports points to increased research and development along with growing inclination of the consumers toward generic drugs, thereby substantially supporting the growth of the United Kingdom generic drugs market in the next five years.

Sedentary Lifestyle Fuels Market Growth

The population in the country is highly inclined to junk food and fast food as a regular consumption along with the increased consumption of alcohol and excessive smoking. The lack of physical workout along with the sedentary lifestyle is the major factor leading to various diseases like obesity, higher blood pressure, diabetes, etc. that may further lead to the chronic diseases like cardiovascular diseases, or cancer. Increasing instances of the diseases and demand for the medicines and other drugs for the treatment drive the growth of the United Kingdom generic drugs market in the upcoming five years.

Although, the population is steadily inclining toward healthier life and losing weight, the demands for the weight loss medicines like Orlistat is increasing and substantiating the growth of the United Kingdom generic drugs market in the next five years. The NHS spent £8,167,383 on Orlistat in 2020 in England. It is the prescription only weight loss aid that is licensed in the country for sale.


Click here to download the sample

Market Segmentation

The United Kingdom generic drugs market is segmented by type, mode of drug delivery, form, source, distribution channel, application, competitional landscape, and regional distribution. Based on type, the market is differentiated between small molecule generics and biosimilars. By mode of drug delivery, the market is further segmented into oral, topical, parenteral, and others. Based on form, the market is fragmented into tablet, capsule, injection, and others. By source, the market is differentiated into in house and contract manufacturing organizations. Based on distribution channel, the market is bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. By application, the market is also segmented into cardiovascular diseases, diabetes, neurology, oncology, anti-inflammatory diseases, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside.

Company Profile

GlaxoSmithKline Plc., Abbott Laboratories Limited, Eli Lilly and Company Limited, Teva UK Limited, Mylan UK Healthcare Limited, Pfizer Limited, Novartis UK Limited, Sun Pharmaceuticals UK Limited, among others is a partial list of major market players of the companies responsible for the growth of United Kingdom generic drugs market.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Type

·         By Mode of Drug Delivery

·         Form

·         Source

·         Distribution Channel

·         Application

Regional scope

London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside

Key companies profiled

GlaxoSmithKline Plc., Abbott Laboratories Limited, Eli Lilly and Company Limited, Teva UK Limited, Mylan UK Healthcare Limited, Pfizer Limited, Novartis UK Limited, Sun Pharmaceuticals UK Limited

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, United Kingdom generic drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • United Kingdom Generic Drugs Market, By Type:
    • Small Molecule Generics
    • Biosimilars
  • United Kingdom Generic Drugs Market, By Mode of Drug Delivery:
    • Oral
    • Topical
    • Parenteral
    • Others
  • United Kingdom Generic Drugs Market, By Form:
    • Tablet
    • Capsule
    • Injection
    • Others
  • United Kingdom Generic Drugs Market, By Source:
    • In House
    • Contract Manufacturing Organizations
  • United Kingdom Generic Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • United Kingdom Generic Drugs Market, By Application:
    • Cardiovascular Diseases
    • Diabetes
    • Neurology
    • Oncology
    • Anti-Inflammatory Diseases
    • Others
  • United Kingdom Generic Drugs Market, By Region:

o   London

o   East Anglia

o   Southwest

o   Southeast

o   Scotland

o   East Midlands

o   Yorkshire & Humberside

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United Kingdom generic drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).


United Kingdom Generic Drugs Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United Kingdom Generic Drugs Market

4.    Voice of Customer

5.    Executive Summary

6.    United Kingdom Generic Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Small Molecule Generics v/s Biosimilars)

6.2.2.     By Mode of Drug Delivery (Oral, Topical, Parenteral, Others)

6.2.3.     By Form (Tablet, Capsule, Injection, Others)

6.2.4.     By Source (In House v/s Contract Manufacturing Organizations)

6.2.5.     By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

6.2.6.     By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others)

6.2.7.     By Company (2021)

6.2.8.     By Region

6.3.  Product Market Map

7.    United Kingdom Small Molecule Generic Drugs Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Mode of Drug Delivery

7.2.2.     By Form

7.2.3.     By Source

7.2.4.     By Distribution Channel

7.2.5.     By Application

8.    United Kingdom Biosimilar Generic Drugs Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Mode of Drug Delivery

8.2.2.     By Form

8.2.3.     By Source

8.2.4.     By Distribution Channel

8.2.5.     By Application

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  United Kingdom Economic Profile

13.  Competitive Landscape

13.1.              GlaxoSmithKline Plc.

13.2.              Abbott Laboratories Limited

13.3.              Eli Lilly and Company Limited

13.4.              Teva UK Limited

13.5.              Mylan UK Healthcare Limited

13.6.              Pfizer Limited

13.7.              Novartis UK Limited

13.8.              Sun Pharmaceuticals UK Limited

14.  Strategic Recommendations

                                                                                               (Note: The companies list can be customized based on the client requirements.)

Figures and Tables

Frequently asked questions

down-arrow

United Kingdom generic drugs market is anticipated to grow with an impressive CAGR during the forecast period, 2023-2027, on account of expanding pharmaceutical industry.

down-arrow

Based on form, the market is segmented into tablet, capsule, injection, and others. Tablets & capsules are cumulatively anticipated to lead the market growth in the upcoming five years due to easier administration of the drug and compatible choices of the population at large.

down-arrow

Being responsible for the due growth of the market, some of the leading players of the United Kingdom generic drugs market were GlaxoSmithKline Plc., Abbott Laboratories Limited, Eli Lilly and Company Limited, Teva UK Limited, Mylan UK Healthcare Limited, Pfizer Limited, Novartis UK Limited, Sun Pharmaceuticals UK Limited, among others.

down-arrow

New market players may invest actively in research and innovative product development. Also, advancing their existent technology according to evolving consumer preferences along with merger and acquisitions with the global giants can be viable strategic recommendations for the future brand establishments.

profile

Sakshi Bajaal

Business Consultant
Press Release

United Kingdom Generic Drugs Market Led To Growth By Obesity Control Medicines

May, 2022

The United Kingdom Generic Drugs Market, 2023-2027F may grow with expanding pharmaceutical industry in the country.